Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

1&1 Aktie 868900 / DE0005545503

11.11.2025 07:31:03

EQS-News: 1&1 with development according to plan in the first nine months of 2025, forecast for 2025 confirmed

EQS-News: 1&1 AG / Key word(s): Quarterly / Interim Statement/Forecast
1&1 with development according to plan in the first nine months of 2025, forecast for 2025 confirmed

11.11.2025 / 07:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


1&1 with development according to plan in the first nine months of 2025, forecast for 2025 confirmed

 

  • Customer contracts at 16.34 million
  • Service revenues unchanged at €2,479.3 million
  • - 3.0 percent EBITDA (operational) to €611.0 million
  • - 11.5 percent EBITDA (total) to €409.8 million, due to higher start-up costs for the 1&1 mobile network as planned
  • Revenue and earnings forecast for 2025 confirmed

 

Montabaur, 11 November 2025 – 1&1 AG (ISIN DE 0005545503) recorded a decline of 50,000 contracts to 16.34 million customer contracts in the first nine months of 2025 (December 31, 2024: 16.39 million contracts. While broadband connections declined as expected by 90,000 contracts to 3.86 million (December 31, 2024: 3.95 million contracts), mobile internet contracts increased again by 40,000 new contracts to 12.48 million contracts (December 31, 2024: 12.44 million contracts). The increase in mobile internet contracts is entirely attributable to the third quarter.

Overall, revenue reached €3,016.2 million, remaining at the previous year's level (9M 2024: €3,017.2 million). While high-margin service revenue in the first nine months of 2025 was - as planned - slightly above the previous year's level at €2,479.3 million (9M 2024: €2,478.7 million), low-margin hardware sales remained slightly below the previous year's level at €536.9 million (9M 2024: €538.5 million).

In the first nine months of 2025, EBITDA in the Access operating segment declined by 3.0% to €611.0 million (9M 2024: €630.1 million). At the same time, start-up costs for the 1&1 mobile network increased as planned to -€201.2 million (9M 2024: -€167.1 million).

Overall, EBITDA declined by 11.5% to €409.8 million (9M 2024: €463.0 million).

Due to lower EBITDA and increased depreciation and amortization, particularly as a result of the growing number of antenna sites in the 1&1 mobile network, EBIT declined to €175,4 million (9M 2024: €287.5 million). As a result, earnings per share (EPS) in the first nine months came to €0,63 (9M 2024: €1.11). Excluding the impact of PPA write-downs, earnings per share amounted to €0,86 (9M 2024: €1.28).

The investment volume (cash capex) amounted to €228,7 million (9M 2024: €70.8 million).

Forecast 2025

The company confirms its service revenue and earnings forecast and expects for 2025 a stable contract base and service revenue at the previous year's level (2024: €3,303.1 million).

EBITDA is expected to decline to approx. 545 million (2024: €590.8 million). This decline is due to a lower EBITDA in the Access segment, which is expected to reach approx. €810 million (2024: €856.1 million).

EBITDA in the 1&1 Mobile Network segment is expected to remain unchanged at approx. -€265 million (2024: -€265.3 million). This includes approximately -€100 million in expenses for customer migration and for network services, which will no longer apply after the complete migration of all customers starting from 2026.

The investment volume (cash capex) is now expected to amount to approx. €400 million (previous forecast: approx. €450 million; 2024: €290.6 million).

 

Performance indicators pursuant to IFRS — comparison 9M 2024 vs. 9M 2025

in €m 9M 2024 9M 2025 Change
Revenue
thereof service revenue
3.017,2
2.478,7
3,016.2
2,479.3
-0.0 %
+0.0 %
EBITDA
thereof segment Access
thereof segment 1&1 Mobile Network
463,0
630,1
-167,1
409.8
611.0
-201.2
-11.5 %
-3.0 %
 
EBIT 287,5 175.4 -39.0 %
       
Earnings per share in € 1,11 0.63 -43.2 %
       
Customer contracts in million 16,35 16,34 -0.3 %

 

This quarterly statement will be made available on the Company’s home page on 11 November 2025.

https://www.1und1.ag/investor-relations-en#meldungen-berichte-praesentationen

 

Montabaur, 11 November 2025

 

1&1 AG

The Management Board

 

About 1&1 AG

1&1 AG, headquartered in Montabaur, is a listed telecommunications provider and part of the United Internet Group.

With a focus on the German market, 1&1 specifically strengthens the country's digital sovereignty. 1&1 is the first network operator in Europe to operate a fully virtualised 5G mobile network based on the new Open RAN technology - independent, technology-agnostic and ready for real-time-applications of the future. As the fourth network, 1&1 O-RAN stands for more competition and innovation in the German mobile communications landscape.

In addition to a comprehensive mobile communications portfolio, broadband connections are offered which are based on 1&1 Versatel's Germany-wide fibre-optic transport network and on networks of regional city carriers as well as of Deutsche Telekom.

While the 1&1 brand addresses value and premium segments, the Group's discount brands appeal to price-conscious target groups



11.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: 1&1 AG
Elgendorfer Strasse 57
56410 Montabaur
Germany
Phone: +49 (0) 6181 - 412 218
Fax: +49 (0) 6181 - 412 183
E-mail: ir@1und1.de
Internet: www.1und1.AG
ISIN: DE0005545503
WKN: 554550
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2227150

 
End of News EQS News Service

2227150  11.11.2025 CET/CEST

Analysen zu 1&1 AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
10:44 1&1 Underperform Bernstein Research
22.09.25 1&1 Halten DZ BANK
01.09.25 1&1 Buy UBS AG
15.08.25 1&1 Halten DZ BANK
08.08.25 1&1 Buy Deutsche Bank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’044.54 19.77 B7ZS2U
Short 13’312.07 13.84 BKPSVU
Short 13’811.57 8.90 SI9BRU
SMI-Kurs: 12’576.97 11.11.2025 11:23:29
Long 12’024.85 19.46 SZ8B6U
Long 11’750.70 13.69 SHFB5U
Long 11’271.58 8.99 SJ9BIU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

1&1 AG 32.14 0.56% 1&1 AG